GO:0072001 renal system development: Embryonic Organogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072001 (renal system development) describes the biological process by which the renal system progresses from formation to a mature structure that maintains fluid, electrolyte and acid/base balance and disposes of nitrogenous waste.
• An intact renin-angiotensin system is a prerequisite for normal renal development, and its disruption leads to permanent structural and functional deficits.
• Integrin-mediated cell-matrix adhesion is essential for ureteric bud branching, nephron differentiation and glomerular assembly during renal development.
• The intrarenal kallikrein-kinin system is developmentally regulated and has been proposed to participate in nephrogenesis and postnatal renal maturation.
• Renal ontogeny is a major determinant of drug disposition in neonates and children, making developmental stage a critical variable in pediatric pharmacology.
• Age-related changes in renal physiology affect drug handling and fluid balance in geriatric patients, underscoring the lifelong importance of renal system development.
Description
Renal system development (GO:0072001) is the biological process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products; in humans it comprises a pair of kidneys, a pair of ureters, the urinary bladder, urethra, sphincter muscle and associated blood vessels. Understanding this process is fundamental because congenital anomalies of the kidney and urinary tract are among the most common birth defects, and because the developmental program sets the structural and functional reserve that persists throughout life. Mechanistically, renal system development depends on reciprocal inductive interactions between the ureteric bud and the metanephric mesenchyme, a process that is critically dependent on an intact renin-angiotensin system. The (pro)renin receptor (Atp6ap2) has been shown to exert functions at molecular and system levels with pathological implications in hypertension, renal and brain development, inflammation, and fibrosis. Integrins provide the adhesive framework that supports branching morphogenesis, nephron differentiation and glomerular assembly. In parallel, the intrarenal kallikrein-kinin system is developmentally regulated and has been proposed to play a role in renal development. For researchers, GO:0072001 provides a controlled vocabulary to annotate genes, pathways and phenotypes across model organisms and human studies. Because renal ontogeny directly influences drug disposition in neonates and children, and because age-related renal changes affect geriatric pharmacology, this term bridges developmental biology, nephrology, pharmacology and genetics. It is therefore a high-value target for CRISPR-based functional genomics, disease modeling and therapeutic development.
renal system development At A Glance
| GO ID | GO:0072001 |
|---|---|
| GO term | renal system development |
| Ontology | biological_process |
| Synonym | urinary system development; urinary tract development |
| Major function | Progression of the renal system from formation to mature structure, maintaining fluid, electrolyte and acid/base balance and disposing of nitrogenous waste |
| Key anatomical components | Pair of kidneys, pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels |
| Major regulatory system | Renin-angiotensin system, including the (pro)renin receptor Atp6ap2 |
| Adhesion machinery | Integrins and extracellular matrix interactions |
| Developmental peptide system | Intrarenal kallikrein-kinin system |
| Clinical relevance | Pediatric renal ontogeny affects drug development; geriatric renal physiology affects drug handling |
What Is GO:0072001?
In our own words, GO:0072001 (renal system development) is the developmental program that builds and matures the entire renal system, including the kidneys, ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels. The process begins with the formation of the renal primordia and proceeds through branching morphogenesis, nephron induction and differentiation, glomerular assembly, and postnatal maturation of the medulla and concentrating ability. Its functional endpoint is a system that maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products.
Why Is renal system development Important in Cell Biology?
Renal system development is important because it establishes the structural and functional capacity of the kidney and urinary tract for the entire lifespan, and because disruption of this program causes congenital and acquired renal disease. An intact renin-angiotensin system is a prerequisite for normal renal development, and its blockade or genetic disruption produces permanent deficits in nephron number, medullary architecture and concentrating ability. The (pro)renin receptor Atp6ap2 links developmental signaling to hypertension, inflammation and fibrosis, making it a node where developmental biology and adult disease converge. Integrin-mediated adhesion is required for branching morphogenesis and glomerular assembly, so defects in these molecules impair nephrogenesis. The kallikrein-kinin system is developmentally regulated and has been proposed to participate in renal development, adding another layer of developmental control. Finally, because renal ontogeny determines drug disposition in neonates and children, and because age-related renal changes affect geriatric patients, understanding GO:0072001 has direct pharmacological and clinical importance.
• Defines the developmental program that builds kidneys, ureters, bladder, urethra, sphincter muscle and associated blood vessels.
• An intact renin-angiotensin system is required for normal renal development; its disruption causes permanent structural and functional deficits.
• The (pro)renin receptor Atp6ap2 has molecular and system-level functions with pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.
• Integrins mediate cell-matrix adhesion essential for ureteric bud branching, nephron differentiation and glomerular assembly.
• The intrarenal kallikrein-kinin system is developmentally regulated and proposed to play a role in renal development.
• Renal ontogeny determines drug disposition in neonates and children, informing pediatric drug development.
• Age-related changes in renal physiology affect drug handling and fluid balance in geriatric patients.
• Provides a controlled vocabulary for annotating genes, pathways and phenotypes in nephrology and developmental biology.
• Supports CRISPR-based functional genomics and disease modeling of congenital renal anomalies.
• Connects developmental mechanisms to adult diseases such as hypertension and renal fibrosis.
What Happens During renal system development?
Formation of the renal primordia and ureteric bud induction
In simple terms: The kidney starts as two early embryonic tissues that signal to each other to begin building the organ.
Renal system development begins with the formation of the renal primordia and the induction of the ureteric bud from the Wolffian duct. This early step depends on reciprocal inductive interactions between the ureteric bud and the metanephric mesenchyme, and an intact renin-angiotensin system is a prerequisite for normal progression of this program. The (pro)renin receptor Atp6ap2 has been implicated in molecular and system-level functions relevant to renal development, including signaling that influences developmental outcomes. Disruption of these early inductive events leads to permanent deficits in renal structure and function.
Branching morphogenesis and nephron induction
In simple terms: The growing ureteric bud branches repeatedly like a tree, and each new branch triggers the formation of nephrons.
Following induction, the ureteric bud undergoes branching morphogenesis to generate the collecting system, while the surrounding mesenchyme is induced to form nephrons. Integrin-mediated cell-matrix adhesion is essential for this process, supporting branching morphogenesis, nephron differentiation and glomerular assembly. The intrarenal kallikrein-kinin system is developmentally regulated during this period and has been proposed to participate in nephrogenesis. An intact renin-angiotensin system is required for normal branching and nephron endowment, and its disruption reduces nephron number and impairs renal architecture.
Nephron differentiation and glomerular assembly
In simple terms: The newly induced cells mature into the filtering units of the kidney, including the glomerulus.
During nephron differentiation, mesenchymal cells undergo a mesenchymal-to-epithelial transition and assemble into polarized tubular epithelia, while endothelial and podocyte precursors cooperate to form the glomerulus. Integrins are critical for glomerular assembly and for maintaining the adhesion of podocytes and endothelial cells to the glomerular basement membrane. The renin-angiotensin system contributes to the maturation of glomerular and tubular structures, and its blockade during development impairs nephron differentiation. The (pro)renin receptor Atp6ap2 has been linked to signaling pathways that influence renal developmental outcomes and fibrosis.
Postnatal maturation of the renal medulla and concentrating ability
In simple terms: After birth, the inner part of the kidney continues to mature so it can concentrate urine.
Postnatal development of the renal medulla is a critical phase in which the loop of Henle and medullary architecture mature to establish the urinary concentrating mechanism. The renin-angiotensin system plays a role in this postnatal medullary development, and its disruption impairs medullary maturation and concentrating ability. This phase is also relevant to pediatric pharmacology, because renal ontogeny determines drug disposition in neonates and children. Age-related changes in renal physiology continue to affect fluid and electrolyte handling in geriatric patients.
Integration of vascular and urinary tract development
In simple terms: The kidney's blood vessels and the urinary drainage tubes must develop together with the kidney.
Renal system development includes the coordinated formation of the renal vasculature and the urinary tract, comprising the ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels. The renin-angiotensin system influences vascular development and blood pressure regulation, and its intact function is required for normal renal development. The (pro)renin receptor Atp6ap2 has system-level functions relevant to hypertension and renal development, linking vascular and developmental programs. Integrin-mediated adhesion supports the assembly of vascular and glomerular structures.
Key Genes Involved in GO:0072001 renal system development
The following genes and proteins have been experimentally implicated in renal system development (GO:0072001) and related regulatory systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| REN | Renin is the rate-limiting enzyme of the renin-angiotensin system, which is required for normal renal development. | Target for studying developmental blockade and nephron endowment. |
| AGT | Angiotensinogen is the substrate of renin and a component of the renin-angiotensin system required for renal development. | Genetic models of RAS disruption and renal developmental deficits. |
| ACE | Angiotensin-converting enzyme generates angiotensin II, a key effector of the renin-angiotensin system in renal development. | Pharmacological and genetic studies of renal developmental blockade. |
| AGTR1 | Angiotensin II receptor type 1 mediates effects of the renin-angiotensin system on renal development. | Knockout and point-mutation models of impaired nephrogenesis. |
| ATP6AP2 | The (pro)renin receptor has molecular and system-level functions with implications in hypertension, renal and brain development, inflammation, and fibrosis. | Central node linking developmental signaling to adult renal disease. |
| ITGB1 | Integrin beta 1 mediates cell-matrix adhesion essential for renal development. | Conditional knockout models of branching morphogenesis and glomerular assembly. |
| ITGA3 | Integrin alpha 3 participates in cell-matrix interactions during nephron differentiation. | Models of glomerular and tubular developmental defects. |
| ITGA8 | Integrin alpha 8 is involved in mesenchymal-epithelial interactions during renal development. | Knockout models of impaired nephrogenesis. |
| KLK1 | Tissue kallikrein is a component of the intrarenal kallikrein-kinin system proposed to play a role in renal development. | Developmental expression studies and knockout models. |
| KNG1 | Kininogen is a substrate of the kallikrein-kinin system developmentally regulated in the kidney. | Models of developmental kallikrein-kinin system function. |
| BDKRB2 | Bradykinin receptor B2 mediates kinin effects and is part of the intrarenal kallikrein-kinin system. | Receptor knockout models of renal developmental function. |
| WT1 | Wilms tumor 1 is a transcription factor required for metanephric mesenchyme induction and nephron formation. | Models of congenital renal anomalies and Wilms tumor biology. |
| GDNF | Glial cell line-derived neurotrophic factor signals from metanephric mesenchyme to induce ureteric bud branching. | Models of branching morphogenesis and nephron endowment. |
| RET | RET receptor tyrosine kinase transduces GDNF signals during ureteric bud induction and branching. | Knockout and point-mutation models of renal agenesis and dysplasia. |
| PAX2 | Paired box 2 is a transcription factor required for ureteric bud and nephron development. | Models of renal hypoplasia and congenital anomalies. |
| SIX1 | Sine oculis homeobox 1 regulates nephron progenitor maintenance and differentiation. | Models of nephron progenitor depletion. |
| HNF1B | Hepatocyte nuclear factor 1 beta is required for ureteric bud branching and nephron differentiation. | Models of renal cysts and congenital urinary tract anomalies. |
| UMOD | Uromodulin is expressed in the maturing thick ascending limb and is relevant to medullary development. | Models of medullary maturation and concentrating ability. |
How Is renal system development Regulated?
Renal system development is regulated by multiple interacting systems. The renin-angiotensin system is a prerequisite for normal renal development, and its intact function is required for branching morphogenesis, nephron endowment and postnatal medullary maturation. The (pro)renin receptor Atp6ap2 exerts molecular and system-level functions with pathological implications in hypertension, renal and brain development, inflammation, and fibrosis, indicating that it integrates developmental and stress signaling. Integrin-mediated adhesion provides mechanical and signaling inputs that regulate branching morphogenesis and glomerular assembly. The intrarenal kallikrein-kinin system is developmentally regulated and has been proposed to modulate nephrogenesis and postnatal renal maturation. In addition, developmental stage determines drug disposition, so pharmacological regulation of these pathways must account for renal ontogeny in neonates and children.
renal system development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| REN | Impaired renal development and nephron endowment due to renin-angiotensin system disruption | Knockout and conditional knockout models |
| ATP6AP2 | Hypertension, renal developmental defects, inflammation and fibrosis | Conditional knockout and knock-in models |
| ITGB1 | Defective branching morphogenesis and glomerular assembly | Conditional knockout in renal progenitors |
| RET | Renal agenesis and dysplasia due to impaired ureteric bud induction | Point-mutation and knockout models |
| UMOD | Impaired medullary maturation and concentrating ability | Knockout and overexpression models |
Congenital anomalies of the kidney and urinary tract
Disruption of renal system development causes congenital anomalies of the kidney and urinary tract, including renal agenesis, hypoplasia and dysplasia. An intact renin-angiotensin system is a prerequisite for normal renal development, and its blockade or genetic disruption produces permanent structural and functional deficits. Integrin-mediated adhesion defects impair branching morphogenesis and glomerular assembly, contributing to developmental renal anomalies. These conditions are a major cause of pediatric chronic kidney disease and are studied using developmental models of GO:0072001.
Hypertension and renal fibrosis
The (pro)renin receptor Atp6ap2 has molecular and system-level functions with pathological implications in hypertension, renal and brain development, inflammation, and fibrosis. Because the renin-angiotensin system is required for normal renal development, developmental programming of this system influences adult blood pressure regulation and renal injury susceptibility. These links make GO:0072001 relevant to the developmental origins of hypertension and progressive renal fibrosis.
Pediatric pharmacology and drug disposition
Renal ontogeny determines drug disposition in neonates and children, so developmental stage is a critical variable in pediatric drug development. Because renal system development continues postnatally, including maturation of the renal medulla, drug dosing must account for the developmental trajectory of renal function. This has direct implications for the safe use of renin-angiotensin system-targeting drugs during development.
Geriatric renal physiology
Age-related changes in renal physiology affect drug handling and fluid balance in geriatric patients, reflecting the long-term consequences of renal system development and aging. Understanding the developmental program of GO:0072001 provides a baseline against which age-related decline can be interpreted. This is relevant to dosing and monitoring of renally cleared drugs in older adults.
From renal system development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for ureteric bud branching? | Knockout or conditional knockout in renal progenitor cells |
| Does a specific variant impair nephron differentiation? | Point-mutation knock-in of the variant |
| Does a developmental signaling protein localize to specific renal structures? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a pathway component alter nephron endowment? | Overexpression transgenic model |
| Does disruption of the renin-angiotensin system impair medullary maturation? | Conditional knockout or pharmacological blockade model |
| Does a candidate gene regulate integrin-dependent adhesion during nephrogenesis? | Knockout combined with adhesion and imaging assays |
How to Study the renal system development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Transcript abundance across developmental stages | Identifying genes annotated to GO:0072001 |
| Conditional knockout | Requirement of a gene in a specific renal lineage | Testing essentiality in branching morphogenesis |
| Pharmacological blockade | Effect of pathway inhibition on renal development | Renin-angiotensin system studies |
| Immunofluorescence and confocal imaging | Protein localization and tissue architecture | Assessing integrin and glomerular assembly |
| Lineage tracing | Origin and fate of renal progenitor cells | Mapping nephron and collecting duct lineages |
| Histology of renal medulla | Medullary architecture and maturation | Postnatal medullary development studies |
| Urinary concentrating tests | Functional concentrating ability | Assessing medullary maturation |
| Blood pressure and electrolyte measurements | System-level renal function | Linking developmental programs to adult physiology |
Transcriptomic profiling of developing renal tissues
RNA sequencing of microdissected renal primordia, ureteric bud and metanephric mesenchyme at defined developmental stages identifies genes and pathways annotated to GO:0072001. This approach has been used to characterize developmental expression of the intrarenal kallikrein-kinin system and renin-angiotensin system components. Comparative transcriptomics across developmental stages reveals the timing of nephron differentiation and medullary maturation programs.
Genetic and pharmacological perturbation in model organisms
Knockout, conditional knockout and pharmacological blockade models are used to test whether a gene is required for renal system development. An intact renin-angiotensin system is a prerequisite for normal renal development, and its disruption produces measurable structural and functional deficits. Integrin knockout models have demonstrated the requirement for cell-matrix adhesion in branching morphogenesis and glomerular assembly. The (pro)renin receptor Atp6ap2 has been studied using genetic models that reveal molecular and system-level functions.
Imaging and morphological analysis of nephrogenesis
Confocal and light-sheet imaging of whole-mount kidneys, combined with lineage tracing and immunofluorescence, visualizes ureteric bud branching, nephron formation and glomerular assembly. These methods are used to assess the consequences of integrin and renin-angiotensin system disruption on renal architecture. Postnatal medullary maturation can be assessed by histology and by measuring urinary concentrating ability.
Functional assays of renal physiology
Measurements of glomerular filtration, urinary concentrating ability, electrolyte handling and blood pressure are used to determine the functional consequences of developmental perturbations. Postnatal development of the renal medulla and the role of the renin-angiotensin system have been assessed using such physiological assays. These assays are also relevant to pediatric and geriatric pharmacology, where renal ontogeny and aging affect drug disposition.
How CRISPR Can Be Used to Study GO:0072001 renal system development
Knockout
CRISPR knockout of candidate genes in renal progenitor cell lines or animal models is used to test whether a gene is required for renal system development. For example, knocking out components of the renin-angiotensin system or integrin subunits can reveal requirements for branching morphogenesis, nephron differentiation and glomerular assembly. Knockout of Atp6ap2 can be used to dissect its molecular and system-level functions in renal development and fibrosis. These models are essential for assigning causal roles to genes annotated to GO:0072001.
Point Mutation
CRISPR point mutation introduces specific disease-associated or functional variants into endogenous loci to test their effects on renal development. Point mutations in renin-angiotensin system genes or integrin genes can be modeled to determine whether a single amino acid change impairs nephrogenesis. This approach is particularly valuable for variants identified in patients with congenital anomalies of the kidney and urinary tract.
Knock-in
CRISPR knock-in can be used to insert fluorescent or epitope tags into endogenous renal developmental genes, enabling visualization of protein localization and dynamics during nephrogenesis. Tagged knock-in of integrins or renin-angiotensin system components allows tracking of these proteins in branching ureteric bud and forming nephrons. Knock-in of reporter cassettes can also be used to isolate specific renal progenitor populations for transcriptomic analysis.
Overexpression
CRISPR-mediated overexpression or transgenic overexpression of candidate genes is used to test whether increased dosage of a developmental regulator alters nephron endowment or medullary maturation. Overexpression of renin-angiotensin system components or the (pro)renin receptor Atp6ap2 can reveal gain-of-function effects relevant to hypertension and renal fibrosis. Overexpression models complement knockout studies to establish sufficiency versus necessity in renal system development.
How EDITGENE Supports renal system development Research
Researchers studying renal system development-related genes often need to determine whether a candidate gene is causally involved in nephrogenesis, branching morphogenesis or medullary maturation, or whether it is merely a correlative marker. Establishing causality requires precise genetic perturbation in relevant cellular and animal models, combined with functional and imaging readouts. EDITGENE provides end-to-end CRISPR services to generate such models and to interpret the resulting data in the context of GO:0072001.
Contact EDITGENE today to design your custom CRISPR model for renal system development research.
Frequently Asked Questions About renal system development
What is GO:0072001 renal system development?
GO:0072001 is the biological process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure; the renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products.
What genes are involved in renal system development?
Genes involved include renin-angiotensin system components such as REN, AGT, ACE and AGTR1, the (pro)renin receptor ATP6AP2, integrins such as ITGB1, ITGA3 and ITGA8, kallikrein-kinin system components such as KLK1, KNG1 and BDKRB2, and developmental transcription factors such as WT1, PAX2, SIX1 and HNF1B.
Why is the renin-angiotensin system important for renal development?
An intact renin-angiotensin system is a prerequisite for normal renal development, and its disruption leads to permanent structural and functional deficits, including impaired branching morphogenesis and medullary maturation.
What is the role of integrins in renal development?
Integrins mediate cell-matrix adhesion essential for ureteric bud branching, nephron differentiation and glomerular assembly during renal development.
What is the role of the (pro)renin receptor Atp6ap2 in renal development?
Atp6ap2 has molecular and system-level functions with pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.
How is the kallikrein-kinin system involved in renal development?
The intrarenal kallikrein-kinin system is developmentally regulated and has been proposed to play a role in renal development and postnatal renal maturation.
Why does renal ontogeny matter for drug development?
Renal ontogeny determines drug disposition in neonates and children, making developmental stage a critical variable in pediatric drug development.
How does aging affect renal physiology?
Age-related changes in renal physiology affect drug handling and fluid balance in geriatric patients, reflecting the long-term consequences of renal system development and aging.
What research methods are used to study renal system development?
Common methods include RNA sequencing, conditional knockout and pharmacological blockade models, immunofluorescence and confocal imaging, lineage tracing, histology of the renal medulla, urinary concentrating tests, and blood pressure and electrolyte measurements.
How can CRISPR be used to study renal system development?
CRISPR knockout, point mutation, knock-in and overexpression models can be used to test the requirement, sufficiency and variant-specific effects of genes in branching morphogenesis, nephron differentiation and glomerular assembly.
Conclusion
GO:0072001 (renal system development) defines the developmental program that builds and matures the kidneys, ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels, establishing the lifelong capacity to maintain fluid, electrolyte and acid/base balance and to dispose of nitrogenous waste. The renin-angiotensin system, the (pro)renin receptor Atp6ap2, integrins and the intrarenal kallikrein-kinin system are central regulators of this process, and their disruption causes permanent renal deficits. Because renal ontogeny influences drug disposition in children and because age-related renal changes affect geriatric patients, this process has broad pharmacological and clinical relevance. CRISPR-based functional genomics provides a powerful approach to dissect the causal roles of genes annotated to GO:0072001. By combining knockout, point-mutation, knock-in and overexpression models with transcriptomic, imaging and physiological readouts, researchers can move from correlation to causation in renal developmental biology. EDITGENE supports this workflow with end-to-end CRISPR services and bioinformatics tailored to renal system development research.
References
- 1. Alvis BD et al.. 2015. Physiology Considerations in Geriatric Patients.. Anesthesiol Clin 33(3):447-56 PMID: 26315630
- 2. Guron G et al.. 2000. An intact renin-angiotensin system is a prerequisite for normal renal development.. J Hypertens 18(2):123-37 PMID: 10694179
- 3. Madsen K et al.. 2013. Postnatal development of the renal medulla; role of the renin-angiotensin system.. Acta Physiol (Oxf) 208(1):41-9 PMID: 23432903
- 4. Hoffmann N et al.. 2021. Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.. Pharmacol Res 173:105922 PMID: 34607004
- 5. Mathew S et al.. 2012. Integrins in renal development.. Pediatr Nephrol 27(6):891-900 PMID: 21603909
- 6. el-Dahr SS. 1997. Ontogeny of the intrarenal kallikrein-kinin system: proposed role in renal development.. Microsc Res Tech 39(3):222-32 PMID: 9372496
- 7. el-Dahr SS. 1994. Development biology of the renal kallikrein-kinin system.. Pediatr Nephrol 8(5):624-31 PMID: 7819016
- 8. Zhang Y et al.. 2019. Pediatric Renal Ontogeny and Applications in Drug Development.. J Clin Pharmacol 59 Suppl 1:S9-S20 PMID: 31502684
